Celsion

$2.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.94%) As of 5:27 PM UTC today

Why Robinhood?

You can buy or sell Celsion and other stocks, options, and ETFs commission-free!

About CLSN

Celsion Corporation Common Stock, also called Celsion, is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ. The listed name for CLSN is Celsion Corporation Common Stock.

CEO
Michael H. Tardugno
Employees
29
Headquarters
Lawrenceville, New Jersey
Founded
1982
Market Cap
130.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
44.57M
High Today
$2.19
Low Today
$2.03
Open Price
$2.12
Volume
3.13M
52 Week High
$6.50
52 Week Low
$0.4305

CLSN Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 24, Pre-Market

You May Also Like

EDTK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure